NASDAQ: SGHTSight Sciences Inc Stock Ownership - Who owns Sight Sciences?
Insider buying vs selling
Have Sight Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Badawi | Chief Technology Officer | 2025-07-17 | 40,000 | $0.12 | $4.80kBuy |
| David Badawi | Chief Technology Officer | 2025-07-03 | 5,679 | $4.17 | $23.70kSell |
| Jeremy B. Hayden | Chief Legal Officer | 2025-07-03 | 9,160 | $4.17 | $38.23kSell |
| Alison Bauerlein | Chief Financial Officer | 2025-07-02 | 19,260 | $4.10 | $78.93kSell |
| Matthew Link | Chief Commercial Officer | 2025-07-02 | 4,889 | $4.10 | $20.04kSell |
| Paul Badawi | President and CEO | 2025-07-01 | 23,637 | $4.15 | $98.14kSell |
| Staffan Encrantz | Director | 2025-06-06 | 27,900 | $4.22 | $117.74kBuy |
| Staffan Encrantz | Director | 2025-06-05 | 40,951 | $4.24 | $173.80kBuy |
| Staffan Encrantz | Director | 2025-06-04 | 21,674 | $4.17 | $90.42kBuy |
| Staffan Encrantz | Director | 2025-06-03 | 25,230 | $3.97 | $100.09kBuy |
SGHT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SGHT insiders and whales buy or sell their stock.
SGHT Shareholders
What type of owners hold Sight Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Staffan Encrantz | 12.50% | 6,464,884 | $22.89M | Insider |
| Paul Badawi | 11.58% | 5,986,943 | $21.19M | Insider |
| Kck Ltd | 9.24% | 4,776,232 | $16.91M | Insider |
| Long Focus Capital Management LLC | 6.05% | 3,126,508 | $11.07M | Institution |
| D1 Capital Partners LP | 5.80% | 3,000,000 | $10.62M | Insider |
| Jesse Selnick | 5.09% | 2,632,927 | $9.32M | Insider |
| Andrew Offer | 4.56% | 2,358,224 | $8.35M | Insider |
| Blackrock Inc | 4.43% | 2,289,184 | $8.10M | Institution |
| David Badawi | 3.62% | 1,871,025 | $6.62M | Insider |
| Vanguard Group Inc | 3.28% | 1,697,119 | $6.01M | Institution |
SGHT vs Medical Device Stocks
Sight Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.